InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by von Moltke Lisa. Director active across 2 companies, notably Cara Therapeutics, Inc.. Cumulatively, 9 disclosures have been logged. Activity tracked since 1 June 2023. The latest transaction was disclosed on 27 October 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
9 of 9 declarations